Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,445 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy.
Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon SS, Maeda Y, Hosono N, Onozawa M, Kato T, Kim HJ, Hasabou N, Nuthethi R, Tiu R, Levis MJ. Perl AE, et al. Among authors: martinelli g. Transplant Cell Ther. 2023 Apr;29(4):265.e1-265.e10. doi: 10.1016/j.jtct.2022.12.006. Epub 2022 Dec 13. Transplant Cell Ther. 2023. PMID: 36526260 Free PMC article. Clinical Trial.
Biological therapy in elderly patients with acute myeloid leukemia.
Ciotti G, Marconi G, Sperotto A, Giannini MB, Gottardi M, Martinelli G. Ciotti G, et al. Among authors: martinelli g. Expert Opin Biol Ther. 2023 Feb;23(2):175-194. doi: 10.1080/14712598.2023.2174015. Epub 2023 Feb 14. Expert Opin Biol Ther. 2023. PMID: 36715330
Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors.
Schepisi G, Gianni C, Cursano MC, Gallà V, Menna C, Casadei C, Bleve S, Lolli C, Martinelli G, Rosti G, De Giorgi U. Schepisi G, et al. Among authors: martinelli g. Front Immunol. 2023 Feb 13;14:1118610. doi: 10.3389/fimmu.2023.1118610. eCollection 2023. Front Immunol. 2023. PMID: 36860862 Free PMC article. Review.
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors.
Liverani C, Spadazzi C, Ibrahim T, Pieri F, Foca F, Calabrese C, De Vita A, Miserocchi G, Cocchi C, Vanni S, Ercolani G, Cavaliere D, Ranallo N, Chiadini E, Prisinzano G, Severi S, Sansovini M, Martinelli G, Bongiovanni A, Mercatali L. Liverani C, et al. Among authors: martinelli g. Front Endocrinol (Lausanne). 2023 Jan 20;13:1045038. doi: 10.3389/fendo.2022.1045038. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743926 Free PMC article.
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype.
Mallo M, Tuechler H, Arenillas L, Raynaud S, Cluzeau T, Shih LY, Tung-Liang C, Ganster C, Shirneshan K, Haase D, Mascaró M, Palomo L, Cervera J, Such E, Trim N, Jeffries S, Ridgway E, Marconi G, Martinelli G, Solé F. Mallo M, et al. Among authors: martinelli g. EJHaem. 2023 Feb 7;4(2):446-449. doi: 10.1002/jha2.651. eCollection 2023 May. EJHaem. 2023. PMID: 37206269 Free PMC article.
Personalizing precision medicine: Patients with AML perceptions about treatment decisions.
Grauman Å, Kontro M, Haller K, Nier S, Aakko S, Lang K, Zingaretti C, Meggiolaro E, De Padova S, Marconi G, Martinelli G, Heckman CA, Simonetti G, Bullinger L, Kihlbom U. Grauman Å, et al. Among authors: martinelli g. Patient Educ Couns. 2023 Oct;115:107883. doi: 10.1016/j.pec.2023.107883. Epub 2023 Jul 5. Patient Educ Couns. 2023. PMID: 37421687 Free article.
1,445 results